Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sales | 433.42 | 424.16 | 294.66 | 215.84 | 366.82 |
| Operating profit | 71.49 | 63.33 | 36.45 | 24.18 | 112.58 |
| Interest | 7.29 | 6.56 | 7.67 | 3.44 | 6.20 |
| Gross profit | 64.37 | 64.70 | 28.90 | 27.58 | 106.38 |
| EPS (Rs) | 0.93 | 1.07 | 0.30 | 0.30 | 1.75 |
Annual
results in details
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Other income | 0.17 | 7.93 | 0.12 | 6.83 | - |
| Stock adjustment | -5.63 | -2.71 | -3.72 | 0.67 | 4.17 |
| Raw material | 209.20 | 208.14 | 154.74 | 100.88 | 156.72 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 48.51 | 46.33 | 45.86 | 40.17 | 26.13 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 109.85 | 109.07 | 61.34 | 49.93 | 67.22 |
| Provisions made | - | - | - | - | - |
| Depreciation | 11.64 | 8.69 | 12.25 | 15.00 | 14.75 |
| Taxation | 14.82 | 12.39 | 4.23 | 0.35 | 20.14 |
| Net profit / loss | 37.90 | 43.62 | 12.43 | 12.23 | 71.49 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 16.49 | 14.93 | 12.37 | 11.20 | 30.69 |
| GPM (%) | 14.85 | 14.97 | 9.80 | 12.39 | - |
| NPM (%) | 8.74 | 10.09 | 4.22 | 5.49 | - |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis